Home › Immunoglobulin Light-chain Amyloidosis › Ohio
Immunoglobulin Light-chain Amyloidosis clinical trials in Ohio
5 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in Ohio.
Cities in Ohio
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
- Cleaveland Clinic, Cleveland
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT06569147A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, Cleveland
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07081646Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Case Western Reserve University, Cleveland
- Riverside Methodist Hospital, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06022939Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
- Ohio State University Medical Center, Columbus
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 23, 2026 · NCT01408225Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- The Ohio State University Comprehensive Cancer Center, Columbus
RecruitingObservational study
Ages 40 and older · All sexes · Updated Aug 6, 2025 · NCT06365060From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.